ImmunoCellular Therapeutics (IMUC.OB) licenses Cancer Therapeutic Antibodies
June 2nd, 2011
No comments
IMUC.OB licenses for antibody-dependent cellular cytotoxicity (ADCC) enhanced antibodies Read more…
Categories: ImmunoCellular Therapeutics, IMUC.OB, License
